Cargando…
GRP75-faciliated Mitochondria-associated ER Membrane (MAM) Integrity controls Cisplatin-resistance in Ovarian Cancer Patients
Background: Control of ER-mitochondrial Ca(2+) fluxes is a critical checkpoint to determine cell fate under stress. The 75-kDa glucose-regulated protein (GRP75) is a key tether protein facilitating mitochondria-associated ER membrane (MAM) formation through the IP3R-GRP75-VDAC1 complex. Although GRP...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066115/ https://www.ncbi.nlm.nih.gov/pubmed/35541901 http://dx.doi.org/10.7150/ijbs.71571 |
_version_ | 1784699736273453056 |
---|---|
author | Li, Jing Qi, Fangzheng Su, Huishan Zhang, Chuanshan Zhang, Qing Chen, Ying Chen, Ping Su, Linjia Chen, Yanan Yang, Yuqi Chen, Zhesheng Zhang, Sihe |
author_facet | Li, Jing Qi, Fangzheng Su, Huishan Zhang, Chuanshan Zhang, Qing Chen, Ying Chen, Ping Su, Linjia Chen, Yanan Yang, Yuqi Chen, Zhesheng Zhang, Sihe |
author_sort | Li, Jing |
collection | PubMed |
description | Background: Control of ER-mitochondrial Ca(2+) fluxes is a critical checkpoint to determine cell fate under stress. The 75-kDa glucose-regulated protein (GRP75) is a key tether protein facilitating mitochondria-associated ER membrane (MAM) formation through the IP3R-GRP75-VDAC1 complex. Although GRP75 contributes to cisplatin (CP)-resistance of ovarian cancer (OC), the underlying mechanisms are not clear. Methods: CP-resistant and -sensitive OC cell lines with GRP75 stable modulation were established. Confocal, PLA, co-IP, and TEM analysis were utilized to detect MAM integrity. Live cell Ca(2+) imaging, intracellular ATP, ROS, and NAD(+) assays were utilized to investigate ER-to-mitochondrial Ca(2+) transfer and mitochondrial bioenergetics. Western blot, flow cytometry, CCK-8, Δψm, and mPTP assays were utilized to examine apoptotic cell death. Bioinformatics, patient's specimens, and immunohistochemistry were conducted to obtain the clinical relevance for GRP75-facilitated MAM formation. Results: GRP75-faciliated MAM formation was enriched in CP-resistant OC cells. CP-exposure only increased MAM formation in CP-sensitive OC cells, and enrichment of GRP75 and VDAC1 at MAMs is indispensable to CP-resistance. Diminishing MAM integrity by GRP75-deficiency reduced ER-to-mitochondria Ca(2+) transfer, accelerated CP-induced mitochondrial dysfunction, provoked catastrophic ROS, and enhanced CP-triggered apoptotic cell death in OC cells. Clinical investigations confirmed the enrichment of GRP75-faciliated MAM formation in relapsed OC patients, and such enrichment was associated with the CP-resistance phenotype. Conclusion: GRP75-overexpression confers CP-resistance by distinctively managing MAM-facilitated Ca(2+) fluxes and the pro-survival ROS signal, whereas GRP75-deficiency induces cell death via bioenergetic crisis and apoptotic ROS accumulation in OC cells. Our results show that GRP75-faciliated MAM formation is a potential target to overcome CP-resistance of OC. |
format | Online Article Text |
id | pubmed-9066115 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-90661152022-05-09 GRP75-faciliated Mitochondria-associated ER Membrane (MAM) Integrity controls Cisplatin-resistance in Ovarian Cancer Patients Li, Jing Qi, Fangzheng Su, Huishan Zhang, Chuanshan Zhang, Qing Chen, Ying Chen, Ping Su, Linjia Chen, Yanan Yang, Yuqi Chen, Zhesheng Zhang, Sihe Int J Biol Sci Research Paper Background: Control of ER-mitochondrial Ca(2+) fluxes is a critical checkpoint to determine cell fate under stress. The 75-kDa glucose-regulated protein (GRP75) is a key tether protein facilitating mitochondria-associated ER membrane (MAM) formation through the IP3R-GRP75-VDAC1 complex. Although GRP75 contributes to cisplatin (CP)-resistance of ovarian cancer (OC), the underlying mechanisms are not clear. Methods: CP-resistant and -sensitive OC cell lines with GRP75 stable modulation were established. Confocal, PLA, co-IP, and TEM analysis were utilized to detect MAM integrity. Live cell Ca(2+) imaging, intracellular ATP, ROS, and NAD(+) assays were utilized to investigate ER-to-mitochondrial Ca(2+) transfer and mitochondrial bioenergetics. Western blot, flow cytometry, CCK-8, Δψm, and mPTP assays were utilized to examine apoptotic cell death. Bioinformatics, patient's specimens, and immunohistochemistry were conducted to obtain the clinical relevance for GRP75-facilitated MAM formation. Results: GRP75-faciliated MAM formation was enriched in CP-resistant OC cells. CP-exposure only increased MAM formation in CP-sensitive OC cells, and enrichment of GRP75 and VDAC1 at MAMs is indispensable to CP-resistance. Diminishing MAM integrity by GRP75-deficiency reduced ER-to-mitochondria Ca(2+) transfer, accelerated CP-induced mitochondrial dysfunction, provoked catastrophic ROS, and enhanced CP-triggered apoptotic cell death in OC cells. Clinical investigations confirmed the enrichment of GRP75-faciliated MAM formation in relapsed OC patients, and such enrichment was associated with the CP-resistance phenotype. Conclusion: GRP75-overexpression confers CP-resistance by distinctively managing MAM-facilitated Ca(2+) fluxes and the pro-survival ROS signal, whereas GRP75-deficiency induces cell death via bioenergetic crisis and apoptotic ROS accumulation in OC cells. Our results show that GRP75-faciliated MAM formation is a potential target to overcome CP-resistance of OC. Ivyspring International Publisher 2022-04-11 /pmc/articles/PMC9066115/ /pubmed/35541901 http://dx.doi.org/10.7150/ijbs.71571 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Li, Jing Qi, Fangzheng Su, Huishan Zhang, Chuanshan Zhang, Qing Chen, Ying Chen, Ping Su, Linjia Chen, Yanan Yang, Yuqi Chen, Zhesheng Zhang, Sihe GRP75-faciliated Mitochondria-associated ER Membrane (MAM) Integrity controls Cisplatin-resistance in Ovarian Cancer Patients |
title | GRP75-faciliated Mitochondria-associated ER Membrane (MAM) Integrity controls Cisplatin-resistance in Ovarian Cancer Patients |
title_full | GRP75-faciliated Mitochondria-associated ER Membrane (MAM) Integrity controls Cisplatin-resistance in Ovarian Cancer Patients |
title_fullStr | GRP75-faciliated Mitochondria-associated ER Membrane (MAM) Integrity controls Cisplatin-resistance in Ovarian Cancer Patients |
title_full_unstemmed | GRP75-faciliated Mitochondria-associated ER Membrane (MAM) Integrity controls Cisplatin-resistance in Ovarian Cancer Patients |
title_short | GRP75-faciliated Mitochondria-associated ER Membrane (MAM) Integrity controls Cisplatin-resistance in Ovarian Cancer Patients |
title_sort | grp75-faciliated mitochondria-associated er membrane (mam) integrity controls cisplatin-resistance in ovarian cancer patients |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066115/ https://www.ncbi.nlm.nih.gov/pubmed/35541901 http://dx.doi.org/10.7150/ijbs.71571 |
work_keys_str_mv | AT lijing grp75faciliatedmitochondriaassociatedermembranemamintegritycontrolscisplatinresistanceinovariancancerpatients AT qifangzheng grp75faciliatedmitochondriaassociatedermembranemamintegritycontrolscisplatinresistanceinovariancancerpatients AT suhuishan grp75faciliatedmitochondriaassociatedermembranemamintegritycontrolscisplatinresistanceinovariancancerpatients AT zhangchuanshan grp75faciliatedmitochondriaassociatedermembranemamintegritycontrolscisplatinresistanceinovariancancerpatients AT zhangqing grp75faciliatedmitochondriaassociatedermembranemamintegritycontrolscisplatinresistanceinovariancancerpatients AT chenying grp75faciliatedmitochondriaassociatedermembranemamintegritycontrolscisplatinresistanceinovariancancerpatients AT chenping grp75faciliatedmitochondriaassociatedermembranemamintegritycontrolscisplatinresistanceinovariancancerpatients AT sulinjia grp75faciliatedmitochondriaassociatedermembranemamintegritycontrolscisplatinresistanceinovariancancerpatients AT chenyanan grp75faciliatedmitochondriaassociatedermembranemamintegritycontrolscisplatinresistanceinovariancancerpatients AT yangyuqi grp75faciliatedmitochondriaassociatedermembranemamintegritycontrolscisplatinresistanceinovariancancerpatients AT chenzhesheng grp75faciliatedmitochondriaassociatedermembranemamintegritycontrolscisplatinresistanceinovariancancerpatients AT zhangsihe grp75faciliatedmitochondriaassociatedermembranemamintegritycontrolscisplatinresistanceinovariancancerpatients |